Jeremy C. Lowe***

Partner

Jeremy C. Lowe’s practice focuses on helping clients protect and strategically enhance the value of their products and intellectual property portfolios.  He is a member of the firm’s Intellectual Property, BioMedical and Complex Litigation Practice Groups.

Mr. Lowe has a degree in chemical engineering and has extensive experience in complex intellectual property litigation.  His litigation practice focuses primarily on patent litigation, with a particular emphasis in the mechanical, chemical and pharmaceutical arts.  Examples of recent or ongoing cases handled by Mr. Lowe include:

• Eastman Kodak Co. v. Agfa-Gevaert N.V. and Agfa Corp., Civil Action No. 02-CV-6564 T-B (W.D. N.Y. 2002) (in May 2007, defended to verdict a five-year long patent infringement dispute between two major photographic film manufacturers involving seven patents and over a dozen product lines)
• Pall Corp. v. Cuno Inc., Civil Action No. 03-CV-0092 (JS)(ETB) (E.D.N.Y. 2003) (patent infringement dispute involving filter media packing)
• Mykrolis Corp. v. Pall Corp., Civil Action No. 03-CV-10392 GAO (D. Mass. 2003) (defended filter manufacture against a preliminary injunction request)
• Pall Corp. v. Entegris Corp., Civil Action No. 05-CV-5894-JFB-WDW (E.D. N.Y. 2005) (patent infringement dispute involving filter assembly methods and pre-wet packaging)
• Entegris Corp. v. Pall Corp., Civil Action Nos. 06-10601 and 11494 GAO (D. Mass. 2006) (patent infringement dispute involving quick-connect manifolds utilized in the microchip manufacturing industry)
• Entegris, Inc. v. Pall Corp., 2004, 1440; 2005, 1265 -1266; 2006, 1374 (Fed. Cir. 2006) (relates to C.A. No. 03-CV-10392) (upheld lower court’s ruling that patents were not likely valid for purposes of denial of preliminary injunction)
• Pall Corp. v. Entegris, Inc., Civil Action No. 07-CV-1869 (JS)(ETB) (E.D.N.Y. 2007) (patent infringement dispute involving filter media packing and capsule design)
• Pall Corp. v. BioQuate, Inc., Civil Action No. 07-CV-00686-CG (E.D. Pa. 2007) (patent infringement dispute involving sterile connectors utilized in the biopharmaceutical industry)

Mr. Lowe is an experienced prosecutor and is registered to practice before the U.S. Patent and Trademark Office.  He has prosecuted numerous domestic and international patent applications for the National Institutes of Health and pharmaceutical manufacturers.  He has been involved in several proceedings before the Board of Patent Appeals and Interferences.  Examples of recent interferences handled by Mr. Lowe include:

• Interference No. 104,782 (interested parties included Illinois Tool Works and Kimberly-Clark) (initiated and settled priority dispute involving the paper manufacturing and fabric assembly industries)

• Interference No. 105,481 (interested parties included the National Institutes of Health, Medtronic and Boston Scientific) (initiated and settled priority dispute involving drug-coated stents)

Mr. Lowe’s counseling practice focuses on intellectual property analysis, due diligence, valuation and licensing.  As part of his counseling practice, Mr. Lowe developed a portfolio model called the Patent Playbook™ that attempts to derive maximum value from companies’ global patent assets.  Mr. Lowe is often involved at every stage of product development to help ensure that clients have the freedom to operate in the marketplace.  Mr. Lowe also advises clients involved in complex mergers and acquisitions on due diligence matters concerning patents and other forms of intellectual property.   

Mr. Lowe speaks extensively to both attorneys and business executives about how to manage their portfolios in an increasingly globally competitive environment.  For example, he addressed the Licensing Executives Society about “Avoiding Compulsory Licenses in the Post-eBay Era,” at its Spring 2007 national meeting in Atlanta.

Throughout the United States he has spoken on these and other topics, including: 

• “The Patent Playbook—How Corporate Counsel and Business Executives Can Work Together to Drive Profits from Your Global Patent Assets”
• “Managing Infringement Exposure in the U.S.”
• “Managing U.S. Patent Litigation Overseas”
• “Sweeping Changes to U.S. Patent Law—How Your Company Can Navigate these Uncertain Times”
• “Avoiding Compulsory Licenses in the Post-eBay Era.” 

Before joining the firm, Mr. Lowe was a partner of Leydig, Voit & Mayer, Ltd., and practiced out of that firm’s Chicago office.

Mr. Lowe is currently a voting member of the IPO’s Patent Law Committee, which reviews proposed legislation and recommends legislative changes to the patent laws.

Bar & Court Admissions

• Not licensed to practice in Connecticut
• Illinois
• U.S. District Court for the Northern District of Illinois
• U.S. Court of Appeals for the Federal Circuit
• U.S. Patent and Trademark Office

Education

• Washington University, St. Louis, Missouri, 1999 J.D.
• University of Missouri-Columbia, Columbia, Missouri, 1996 B.S. in Chemical Engineering

Professional Activities

• Intellectual Property Owners Association, Patent Law Committee
• American Intellectual Property Lawyers Association, Patent Law Committee; Licensing and Management of IP Assets Committee; Membership Committee
• Illinois State Bar Association
• American Bar Association
• American Institute of Chemical Engineers
• Licensing Executives Society, Membership Committee
• Washington University School of Law Intellectual Property Law Advisory Board